Transaction DateRecipientSharesTypePriceValue
19th January 2021Andrew Marsh106,600Exercise of derivative$6.10$650,260.00
19th January 2021Andrew Marsh49,918Open or private sale$63.97$3,193,054.79
19th January 2021Andrew Marsh114,120Open or private sale$65.66$7,493,256.14
19th January 2021Andrew Marsh466,668Exercise of derivative$2.14$998,669.52
19th January 2021Andrew Marsh156,051Open or private sale$64.82$10,115,163.40
19th January 2021Andrew Marsh13,482Open or private sale$62.65$844,652.69
19th January 2021Andrew Marsh5,178Open or private sale$68.31$353,713.84
19th January 2021Andrew Marsh101,766Open or private sale$67.73$6,892,305.88
19th January 2021Andrew Marsh132,753Open or private sale$66.58$8,838,708.02
16th December 2020L Lynn Smull9,834Payment by withholding$2.17$21,339.78
Gevo logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.

Gevo, Inc. is a renewable chemicals and next generation biofuels company. The company focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments. The Gevo segment focuses in research and development activities related to the future production of isobutanol.

Ticker: GEVO
Sector: Process Industries
Industry: Chemicals: Specialty
SEC Central Index Key (CIK): 1392380
Employees: 57
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags